WebNov 24, 2000 · Gene Transfer: Clinical Utility for Preventing Graft Arteriopathy Recently, ex vivo E2F decoy transfection without vectors in vascular grafts suppressed neointimal hyperplasia after cardiac bypass surgery in humans. 38 The results demonstrated that the strategy is clinically promising. WebOct 3, 2009 · Graft arteriopathy is detected clinically by radiological techniques. The International Society for Heart and Lung Transplantation registry reported that the …
Alphavbeta3-targeted detection of arteriopathy in transplante…
WebApr 1, 2012 · The Bad: Cardiac Allograft Vasculopathy, Transplant–Associated Coronary Artery Disease, Chronic Graft Arteriopathy, and Chronic Rejection. CAV is a major complication in heart transplantation because it significantly limits long-term graft and patient survival. CAV is a prominent cause of death. Approximately 20% of deaths 1 year … WebDec 15, 2012 · Chronic graft loss is characterized by the development of transplant arteriopathy (TA), which causes progressive ischemic parenchymal obliteration and replacement fibrosis . Several animal studies have demonstrated that alloantibody contributes to the development of TA via complement-dependent and -independent … earls multfill review
The link between IFN-γ and allograft arteriopathy: is the …
WebJul 27, 2000 · Cardiac transplantation as treatment for end-stage cardiac diseases often results in accelerated graft coronary disease in long-term survivors ().This arteriopathy is characterized by diffuse intimal thickening comprised of proliferative vascular smooth muscle cells (SMCs), and many growth factors mediate SMC proliferation by activating cell cycle … WebNov 6, 2000 · Acute rejection and graft arteriopathy in cardiac transplantation limit the long-term survival of recipients; these processes are enhanced by several cytokines and adhesion molecules. Nuclear ... WebChronic rejection (CR) is an immune phenomenon characterized by vasculopathy (intimal hyperplasia, perivasculitis obliterative endarteritis of graft vessels), fibrosis, and atrophy of graft with progressive loss of function that culminates in graft loss. The pathogenesis of CR is poorly defined. cssp marcory